News

A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they divide, a key process in keeping cells healthy. Using yeast, the researchers reveal protein interactions that could explain how the enzyme telomerase is tightly regulated to prevent cells from dividing uncontrollably or aging prematurely.

Bacteria naturally present in the human intestine, known as the gut microbiota, can transform cholesterol-derived bile acids into powerful metabolites that strengthen anti-cancer immunity by blocking androgen signaling, according to a preclinical study led by Weill Cornell Medicine investigators.

Nearly 200 scientists, investors and industry representatives attended Weill Cornell Medicine’s 2025 Biomedical Innovation Conference April 1, sharing their startup journeys and experiences nurturing biomedical advances into health care products and companies.

As chair, Dr. Ehrt seeks to build on the department’s already robust national and international footprint in tuberculosis research and expand its portfolio in other areas of research and innovation.

Dr. Helen Boucher, dean of Tufts University School of Medicine, delivered the Women in Medicine and Science lecture for Weill Cornell Medicine’s seventh annual Diversity Week.   

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a study by Weill Cornell Medicine and New York Genome Center investigators.

Weill Cornell Medicine’s Celebration of Diversity honored leaders who go beyond their official roles, dedicating time, energy and empathy to build inclusive environments. The ceremony, part of the institution’s seventh annual Diversity Week, was held April 7 in Griffis Faculty Club.

Diversity is a tool for truth, not political agendas, said Vincent D. Rougeau,  president of the College of the Holy Cross, in a keynote address.

New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes—not the presence of certain fats, but their suppression.

Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.

A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic pontine glioma (DIPG) is safe, reported Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center investigators.

Dr. Timothy Ryan has been named one of eight academic principal investigators to participate in the SPARK NS Translational Research Program, 2025 cohort.

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine, according to a new study by Weill Cornell Medicine investigators.

Linoleic acid, an omega-6 fatty acid found in seed oils such as soybean and safflower oil, and animal products including pork and eggs, specifically enhances the growth of the hard-to-treat “triple negative” breast cancer subtype, according to a preclinical study led by Weill Cornell Medicine investigators. 

A multi-institutional study co-led by Weill Cornell Medicine finds that pregnancy may offer some protection from developing Long COVID— a condition lasting for months after a person recovers from SARS-CoV-2 infection.

Awards, honors and achievements for the month of March.

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

Graduating Weill Cornell Medicine-Qatar medical students joined their New York City counterparts during Match Day on March 21 to learn where they matched for their residencies.

With a mission to understand how nutrition and metabolism impact the body’s ability to control cancer, four leading research institutions have united under the Weill Cancer Hub East, an innovative, collaborative partnership that aims to transform cancer treatment.

At Weill Cornell Medical College, students have a new tool for polishing their bedside manner and making a diagnosis: an artificial intelligence-powered virtual patient that simulates the doctor-patient interaction.